Connection

M ATASSI to Lymphocyte Activation

This is a "connection" page, showing publications M ATASSI has written about Lymphocyte Activation.
Connection Strength

1.886
  1. Regions recognized on the light chain of botulinum neurotoxin type A by T lymphocytes of SJL and BALB/c mice primed with inactivated toxin. Immunobiology. 2014 Dec; 219(12):950-7.
    View in: PubMed
    Score: 0.377
  2. Responses in vitro of peripheral blood lymphocytes from patients with myasthenia gravis to stimulation with human acetylcholine receptor alpha-chain peptides: analysis in relation to age, thymic abnormality, and ethnicity. Hum Immunol. 2005 Jan; 66(1):32-42.
    View in: PubMed
    Score: 0.194
  3. B-cell activation in vitro by helper T cells specific to a protein region that is recognized both by T cells and by antibodies. Immunol Invest. 1998 May; 27(3):121-34.
    View in: PubMed
    Score: 0.122
  4. Influences of HLA DRB1, DQA1 and DQB1 on T-cell recognition of epitopes and of larger regions of the botulinum neurotoxin molecule. Immunol Lett. 2017 10; 190:257-264.
    View in: PubMed
    Score: 0.116
  5. Injection of inactive Bordetella pertussis and complete Freund's adjuvant with Torpedo californica AChR increases the occurrence of experimental autoimmune myasthenia gravis in C57BL/6 mice. Autoimmunity. 2017 Aug; 50(5):293-305.
    View in: PubMed
    Score: 0.115
  6. Autoimmune T-cell recognition sites of human thyrotropin receptor in Graves' disease. Mol Cell Endocrinol. 1993 Mar; 92(1):77-82.
    View in: PubMed
    Score: 0.085
  7. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients. Autoimmunity. 2012 Mar; 45(2):153-60.
    View in: PubMed
    Score: 0.078
  8. T cells specific for alpha-beta interface regions of hemoglobin recognize the isolated subunit but not the tetramer and indicate presentation without processing. Proc Natl Acad Sci U S A. 1989 Sep; 86(17):6729-33.
    View in: PubMed
    Score: 0.067
  9. Subtle differences in HLA DQ haplotype-associated presentation of AChR alpha-chain peptides may suffice to mediate myasthenia gravis. Autoimmunity. 2006 Jun; 39(4):277-88.
    View in: PubMed
    Score: 0.053
  10. Vaccination with a MHC class II peptide in Alum and inactive pertussis strongly ameliorates clinical MG in C57BL/6 mice. J Neuroimmunol. 2006 Feb; 171(1-2):8-16.
    View in: PubMed
    Score: 0.051
  11. Antigen presentation of myoglobin: profiles of T cell proliferative responses following priming with synthetic overlapping peptides encompassing the entire molecule. Eur J Immunol. 1985 Sep; 15(9):917-22.
    View in: PubMed
    Score: 0.051
  12. Vaccination with a MHC class II peptide attenuates cellular and humoral responses against tAChR and suppresses clinical EAMG. Autoimmunity. 2002 May; 35(3):183-90.
    View in: PubMed
    Score: 0.040
  13. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope. Crit Rev Immunol. 2001; 21(1-3):1-27.
    View in: PubMed
    Score: 0.037
  14. T cells of mice treated with mPEG-myasthenogenic peptide conjugate are involved in protection against EAMG by stimulating lower pathogenic antibody responses. Autoimmunity. 2000; 32(1):45-55.
    View in: PubMed
    Score: 0.034
  15. Genetic control of immune response to sperm whale myoglobin in mice. II. T lymphocyte proliferative response to the synthetic antigenic sites. J Immunol. 1979 Jul; 123(1):182-8.
    View in: PubMed
    Score: 0.033
  16. Intersite helper function of T cells specific for a protein epitope that is not recognized by antibodies. Immunol Invest. 1997 Jun; 26(4):473-89.
    View in: PubMed
    Score: 0.029
  17. Localization of the regions on the C-terminal domain of the heavy chain of botulinum A recognized by T lymphocytes and by antibodies after immunization of mice with pentavalent toxoid. Immunol Invest. 1997 Jun; 26(4):491-504.
    View in: PubMed
    Score: 0.029
  18. Effect of amino acid substitutions within the region 62-76 of I-A beta b on binding with and antigen presentation of Torpedo acetylcholine receptor alpha-chain peptide 146-162. J Immunol. 1995 May 15; 154(10):5245-54.
    View in: PubMed
    Score: 0.025
  19. Profile of the regions of acetylcholine receptor alpha chain recognized by T-lymphocytes and by antibodies in EAMG-susceptible and non-susceptible mouse strains after different periods of immunization with the receptor. Mol Immunol. 1994 Aug; 31(11):833-43.
    View in: PubMed
    Score: 0.024
  20. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance. Adv Exp Med Biol. 1994; 347:65-75.
    View in: PubMed
    Score: 0.023
  21. Epitope-specific suppression of antibody response in experimental autoimmune myasthenia gravis by a monomethoxypolyethylene glycol conjugate of a myasthenogenic synthetic peptide. Proc Natl Acad Sci U S A. 1992 Jul 01; 89(13):5852-6.
    View in: PubMed
    Score: 0.020
  22. DR beta peptides block the antigen-specific response but not the alloresponse of a dual-reactive T-cell clone. Immunol Lett. 1990 Mar-Apr; 24(1):43-7.
    View in: PubMed
    Score: 0.017
  23. Recognition of inter-transmembrane regions of acetylcholine receptor alpha subunit by antibodies, T cells and neurotoxins. Implications for membrane-subunit organization. FEBS Lett. 1988 Feb 15; 228(2):295-300.
    View in: PubMed
    Score: 0.015
  24. T lymphocyte recognition of acetylcholine receptor: localization of the full T cell recognition profile on the extracellular part of the alpha chain of Torpedo californica acetylcholine receptor. Eur J Immunol. 1987 Dec; 17(12):1697-702.
    View in: PubMed
    Score: 0.015
  25. Non-specific peptide size effects in the recognition by site-specific T-cell clones. Demonstration with a T site of myoglobin. Biochem J. 1987 Sep 01; 246(2):307-12.
    View in: PubMed
    Score: 0.015
  26. The regions of T-cell recognition on the extracellular part of the alpha chain of Torpedo californica acetylcholine receptor. Adv Exp Med Biol. 1987; 225:103-13.
    View in: PubMed
    Score: 0.014
  27. T cell recognition of ragweed allergen Ra3: localization of the full T cell recognition profile by synthetic overlapping peptides representing the entire protein chain. Eur J Immunol. 1986 Mar; 16(3):236-40.
    View in: PubMed
    Score: 0.013
  28. Antigen presentation of lysozyme: T-cell recognition of peptide and intact protein after priming with synthetic overlapping peptides comprising the entire protein chain. Immunology. 1985 Sep; 56(1):103-12.
    View in: PubMed
    Score: 0.013
  29. T cell recognition of lysozyme. IV. Localization and genetic control of the continuous T cell recognition sites by synthetic overlapping peptides representing the entire protein chain. J Immunogenet. 1984 Oct-Dec; 11(5-6):327-37.
    View in: PubMed
    Score: 0.012
  30. T cell recognition of myoglobin. Localization of the sites stimulating T cell proliferative responses by synthetic overlapping peptides encompassing the entire molecule. J Immunogenet. 1984 Oct-Dec; 11(5-6):339-53.
    View in: PubMed
    Score: 0.012
  31. T cell recognition of lysozyme. III. Recognition of the 'surface-simulation' synthetic antigenic sites. J Immunogenet. 1984 Jun-Aug; 11(3-4):245-50.
    View in: PubMed
    Score: 0.012
  32. A novel approach for localization of the continuous protein antigenic sites by comprehensive synthetic surface scanning: antibody and T-cell activity to several influenza hemagglutinin synthetic sites. Immunol Commun. 1984; 13(6):539-51.
    View in: PubMed
    Score: 0.011
  33. T cell recognition of lysozyme. II. Shift in specificity during long-term culture determined by synthetic overlapping peptides comprising the entire protein chain. Immunol Commun. 1984; 13(2):161-72.
    View in: PubMed
    Score: 0.011
  34. T-cell recognition of lysozyme. I. Localization of regions stimulating T-cell proliferative response by synthetic overlapping peptides encompassing the entire molecule. Exp Clin Immunogenet. 1984; 1(2):99-111.
    View in: PubMed
    Score: 0.011
  35. Preparation of T-lymphocyte lines and clones with specificities to preselected protein sites by in vitro passage with free synthetic peptides: demonstration with myoglobin sites. Mol Immunol. 1983 Oct; 20(10):1133-7.
    View in: PubMed
    Score: 0.011
  36. T-lymphocyte recognition of sperm-whale myoglobin. Recognition of synthetic peptides carrying antigenic site 5 by myoglobin-primed T-cells. J Immunogenet. 1983 Apr; 10(2):139-49.
    View in: PubMed
    Score: 0.011
  37. T-lymphocyte recognition of sperm-whale myoglobin. Responses of T-cells from mouse strains primed with synthetic peptide carrying antigenic site 5 and relation to antigen presentation. J Immunogenet. 1983 Apr; 10(2):151-60.
    View in: PubMed
    Score: 0.011
  38. T-lymphocyte recognition of sperm-whale myoglobin. Specificity of T-cell recognition following neonatal tolerance with either myoglobin or synthetic peptides of an antigenic site. J Immunogenet. 1983 Apr; 10(2):161-9.
    View in: PubMed
    Score: 0.011
  39. Molecular localization of the full profile of the continuous regions recognized by myoglobin-primed T-cells using synthetic overlapping peptides encompassing the entire molecule. Immunol Commun. 1983; 12(6):593-603.
    View in: PubMed
    Score: 0.011
  40. Immune recognition of serum albumin--XIV. Cross-reactivity by T-lymphocyte proliferation of subdomains 3, 6 and 9 of bovine serum albumin. Mol Immunol. 1982 Feb; 19(2):313-21.
    View in: PubMed
    Score: 0.010
  41. Dissection of the molecular parameters for T-cell recognition of a myoglobin antigenic site. Adv Exp Med Biol. 1982; 150:73-93.
    View in: PubMed
    Score: 0.010
  42. Genetic control and intersite influences on the immune response to sperm whale myoglobin. Adv Exp Med Biol. 1982; 150:97-125.
    View in: PubMed
    Score: 0.010
  43. Genetic control of immune response to sperm whale myoglobin in mice. I. T lymphocyte proliferative response under H-2-linked Ir gene control. J Immunol. 1978 Sep; 121(3):866-8.
    View in: PubMed
    Score: 0.008
  44. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor. Clin Immunol Immunopathol. 1993 Mar; 66(3):230-8.
    View in: PubMed
    Score: 0.005
  45. Characteristics of peptides which compete for presented antigen-binding sites on antigen-presenting cells. Eur J Immunol. 1990 May; 20(5):953-60.
    View in: PubMed
    Score: 0.004
  46. T cell response to myoglobin: a comparison of T cell clones in high-responder and low-responder mice. Eur J Immunol. 1988 Sep; 18(9):1329-35.
    View in: PubMed
    Score: 0.004
  47. Genetic control of the immune response to hemoglobin and its subunits. Adv Exp Med Biol. 1982; 150:127-40.
    View in: PubMed
    Score: 0.002
  48. Myoglobin-reactive T cell clones. Adv Exp Med Biol. 1982; 150:159-82.
    View in: PubMed
    Score: 0.002
  49. Genetic control of the immune response to haemoglobin. I. Demonstration of separate genetic control of the responses to the alpha- and beta-subunits by in vitro lymphocyte proliferation. J Immunogenet. 1981 Aug; 8(4):315-22.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.